Awards for Excellence in Human Research Protection for 2013 were announced
Awards for Excellence in Human Research Protection for 2013 were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.
Winner of the Annual Award for Innovation was the Professionalism and Integrity in Research Program for its P.I. Program Workshop. Created by Dr. James M. DuBois and colleagues at Saint Louis University and Washington University in St. Louiswith funding from the National Institutes of Health, this serves as the first remediation program for researchers who engaged in wrongdoing or persistent noncompliance. The program was developed by a team of clinical, educational, industrial-organizational, and social psychologists, with guidance from experts in research ethics, regulations, and administration.
Winner of the Annual Award for Lifetime Achievement was Will C. van den Hoonaard. Dr. van den Hoonaard has served the research-ethics community in various capacities including the Canadian Interagency Panel on Research Ethics, involvement in research-ethics journals, numerous guest lectures, and author and editor of several books. Dr. van den Hoonaard is Professor Emeritus at the University of New Brunswick, and Research Associate at the Atlantic Centre for Qualitative Research and Analysis, Saint Thomas University. Both universities are located in Fredericton, NB, Canada.
Recipients of an Award of Excellence for Best Practice included:
Recipients of an Award of Excellence for Lifetime Achievement included:
"The Award program offers positive recognition for excellence in the field of human research protection," said Dr. Goldschmidt. "This year's awards continue the high standard that we have seen since the program began. We congratulate the winners." Awards are given for demonstrated excellence in promoting the well being of people who participate in research. The Health Improvement Institute created this Award program. This year's judges were drawn from academic, compliance, consulting, health services, legal, and research review organizations.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.